Patrick Terry

Principal
Cambridge, MA

Patrick Terry, a Principal at Scientia Advisors, heads the company's Pricing, Reimbursement & Market Access practice helping firms in therapeutics, diagnostics and medical devices, develop sound reimbursement strategies, implement market access solutions accelerating delivery of products and services, realize maximum clinical impact, and deliver value-based pricing in modern healthcare delivery systems in both North American and European markets.

With over eighteen years of experience in senior leadership positions as an international investor, board member, chairman, and industry representative, for some of the world's leading life science research and product development companies, Patrick is known worldwide as a research and industry trail blazer. His specialties include applied genomics, stratified genetic medicine, advanced molecular diagnostics, pharmaceutical development, clinical translational medicine, companion diagnostics and intellectual property rights.

Patrick has a deep background working with US and European regulatory agencies, policy groups, health technology assessment organizations, federal and state government agencies, medical professional societies, trade organizations, advocacy groups, centers for Medicare & Medicaid, and private payer & provider groups.

Prior to Scientia Advisors, Patrick co-founded a cutting edge, publicly traded, personalized medicine company, Genomic Health, Inc. [NASDAQ: GHDX], as well as a variety of privately held biotechnology companies. He helped secure nearly a billion US dollars for a number of personalized medicine companies in North American and Europe. He was also instrumental in the creation of organizations which are currently influencing modern healthcare delivery around the world, including the Personalized Medicine Coalition, the European Personalized Medicine Association, and the Coalition for 21st Century Medicine.